We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ondine Biomedical Inc. | LSE:OBI | London | Ordinary Share | CA68234M2058 | COM SHS NPV (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.50 | -7.41% | 6.25 | 6.00 | 6.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 7.00 | 6.25 | 6.75 | 553,436 | 14:52:44 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 638k | -19.37M | -0.0996 | -0.63 | 12.16M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 24/4/2024 | 16:02 | ALNC |  EARNINGS AND TRADING: Nichols trading in line; Ondine revenue doubles |
| 24/4/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Corporate and Trading Update |
| 22/4/2024 | 12:04 | ALNC | Ondine Biomedical celebrates use of Steriwave in Australian hospital |
| 22/4/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Steriwave in first Australian hospital |
| 15/4/2024 | 14:12 | ALNC | Ondine Biomedical's Steriwave reduces SSI's by 32%, study shows |
| 15/4/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. 32% Fewer SSIs After Steriwave Replaced Mupirocin |
| 10/4/2024 | 09:39 | ALNC | Ondine Biomedical shares jump as Steriwave approved by HCA Healthcare |
| 10/4/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Steriwave authorized for use by HCA UK |
| 04/4/2024 | 13:48 | ALNC | Ondine says introduction of Steriwave in ICU market could boost sales |
| 04/4/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Entry into ICU market expands revenue potential |
1 Year Ondine Biomedical Chart |
Intraday Ondine Biomedical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
